Skip to main content
Top
Published in: Clinical Rheumatology 2/2015

01-02-2015 | Brief Report

Discriminating infectious meningitis versus neuropsychiatric involvement in patients with systemic lupus erythematosus: a single-center experience

Authors: Jinyun Chen, Xuebing Feng, Hong Wang, Bingzhu Hua, Congzhu Ding, Bujun Liu, Lingyun Sun

Published in: Clinical Rheumatology | Issue 2/2015

Login to get access

Abstract

The objective of this study is to identify the clinical differences between infectious meningitis and neuropsychiatric systemic lupus erythematosus (NPSLE) in patients with SLE. Clinical manifestations, laboratory test results, and prognoses of 14 SLE patients complicated with various infectious meningitis, hospitalized in the Affiliated Drum Tower Hospital of Nanjing University Medical School in the past 7 years, were reviewed and compared with those of 34 concomitantly treated NPSLE patients. Our study shows that mortality rate was much higher in SLE patients with infectious meningitis than in NPSLE patients. Compared to NPSLE, those with infectious meningitis had lower SLE Disease Activity Index (SLEDAI), but higher doses of corticosteroids 1 month before the occurrence of CNS symptoms. Headache, high fever, and vomiting were more common in patients with infectious meningitis, accompanied with the elevation of C-reactive protein level. Cerebrospinal fluid (CSF) examination showed increased levels of leukocytes and proteins but decreased glucose level in patients with infectious meningitis. We conclude that for SLE patients exhibiting CNS symptoms, high fever, high intake of corticosteroids, and abnormal CSF are important clues for the coexistence of infectious meningitis, especially tuberculous meningitis.
Literature
1.
go back to reference Frieri M (2013) Mechanisms of disease for the clinician: systemic lupus erythematosus. Ann Allergy Asthma Immunol 110(4):228–232PubMedCrossRef Frieri M (2013) Mechanisms of disease for the clinician: systemic lupus erythematosus. Ann Allergy Asthma Immunol 110(4):228–232PubMedCrossRef
2.
go back to reference Feng X et al (2011) Prognostic indicators of hospitalized patients with systemic lupus erythematosus: a large retrospective multicenter study in China. J Rheumatol 38(7):1289–1295PubMedCrossRef Feng X et al (2011) Prognostic indicators of hospitalized patients with systemic lupus erythematosus: a large retrospective multicenter study in China. J Rheumatol 38(7):1289–1295PubMedCrossRef
3.
go back to reference Kim JM et al (2011) Meningitis in Korean patients with systemic lupus erythematosus: analysis of demographics, clinical features and outcomes; experience from affiliated hospitals of the Catholic University of Korea. Lupus 20(5):531–536PubMedCrossRef Kim JM et al (2011) Meningitis in Korean patients with systemic lupus erythematosus: analysis of demographics, clinical features and outcomes; experience from affiliated hospitals of the Catholic University of Korea. Lupus 20(5):531–536PubMedCrossRef
4.
go back to reference Yang CD, Wang XD, Ye S, Gu YY, Bao CD, Wang Y, Chen SL (2007) Clinical features, prognostic and risk factors of central nervous system infections in patients with systemic lupus erythematosus. Clin Rheumatol 26(6):895–901PubMedCrossRef Yang CD, Wang XD, Ye S, Gu YY, Bao CD, Wang Y, Chen SL (2007) Clinical features, prognostic and risk factors of central nervous system infections in patients with systemic lupus erythematosus. Clin Rheumatol 26(6):895–901PubMedCrossRef
5.
go back to reference Vargas PJ, King G, Navarra SV (2009) Central nervous system infections in Filipino patients with systemic lupus erythematosus. Int J Rheum Dis 12(3):234–238PubMedCrossRef Vargas PJ, King G, Navarra SV (2009) Central nervous system infections in Filipino patients with systemic lupus erythematosus. Int J Rheum Dis 12(3):234–238PubMedCrossRef
6.
go back to reference Hung JJ, Ou LS, Lee WI, Huang JL (2005) Central nervous system infections in patients with systemic lupus erythematosus. J Rheumatol 32(1):40–43PubMed Hung JJ, Ou LS, Lee WI, Huang JL (2005) Central nervous system infections in patients with systemic lupus erythematosus. J Rheumatol 32(1):40–43PubMed
7.
go back to reference Xu Y, Xu D, Zhang T, Leng XM, Zhang FC, Zeng XF (2012) The prevalence and clinical characteristics of systemic lupus erythematosus with infectious brain lesions in China. Scand J Rheumatol 41(6):466–471PubMedCrossRef Xu Y, Xu D, Zhang T, Leng XM, Zhang FC, Zeng XF (2012) The prevalence and clinical characteristics of systemic lupus erythematosus with infectious brain lesions in China. Scand J Rheumatol 41(6):466–471PubMedCrossRef
8.
go back to reference Warnatz K et al (2003) Infectious CNS disease as a differential diagnosis in systemic rheumatic diseases: three case reports and a review of the literature. Ann Rheum Dis 62(1):50–57PubMedCentralPubMedCrossRef Warnatz K et al (2003) Infectious CNS disease as a differential diagnosis in systemic rheumatic diseases: three case reports and a review of the literature. Ann Rheum Dis 62(1):50–57PubMedCentralPubMedCrossRef
9.
go back to reference Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725PubMedCrossRef Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725PubMedCrossRef
10.
go back to reference Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients The Committee on Prognosis Studies in SLE. Arthritis Rheum 35(6):630–640PubMedCrossRef Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients The Committee on Prognosis Studies in SLE. Arthritis Rheum 35(6):630–640PubMedCrossRef
11.
go back to reference Gladman DD, Urowitz MB (1999) The SLICC/ACR damage index: progress report and experience in the field. Lupus 8(8):632–637PubMedCrossRef Gladman DD, Urowitz MB (1999) The SLICC/ACR damage index: progress report and experience in the field. Lupus 8(8):632–637PubMedCrossRef
12.
go back to reference Lin H et al (2012) Survival analysis of late-onset systemic lupus erythematosus: a cohort study in China. Clin Rheumatol 31(12):1683–1689PubMedCrossRef Lin H et al (2012) Survival analysis of late-onset systemic lupus erythematosus: a cohort study in China. Clin Rheumatol 31(12):1683–1689PubMedCrossRef
13.
go back to reference Teh CL, Ling GR (2013) Causes and predictors of mortality in hospitalized lupus patient in Sarawak General Hospital, Malaysia. Lupus 22(1):106–111PubMedCrossRef Teh CL, Ling GR (2013) Causes and predictors of mortality in hospitalized lupus patient in Sarawak General Hospital, Malaysia. Lupus 22(1):106–111PubMedCrossRef
14.
go back to reference Zhang L, Wang DX, Ma L (2008) A clinical study of tuberculosis infection in systemic lupus erythematosus. Zhonghua Nei Ke Za Zhi 47(10):808–810PubMed Zhang L, Wang DX, Ma L (2008) A clinical study of tuberculosis infection in systemic lupus erythematosus. Zhonghua Nei Ke Za Zhi 47(10):808–810PubMed
15.
go back to reference Barber C, Gold WL, Fortin PR (2011) Infections in the lupus patient: perspectives on prevention. Curr Opin Rheumatol 23(4):358–365PubMedCrossRef Barber C, Gold WL, Fortin PR (2011) Infections in the lupus patient: perspectives on prevention. Curr Opin Rheumatol 23(4):358–365PubMedCrossRef
16.
go back to reference Falagas ME, Voidonikola PT, Angelousi AG (2007) Tuberculosis in patients with systemic rheumatic or pulmonary diseases treated with glucocorticosteroids and the preventive role of isoniazid: a review of the available evidence. Int J Antimicrob Agents 30(6):477–486PubMedCrossRef Falagas ME, Voidonikola PT, Angelousi AG (2007) Tuberculosis in patients with systemic rheumatic or pulmonary diseases treated with glucocorticosteroids and the preventive role of isoniazid: a review of the available evidence. Int J Antimicrob Agents 30(6):477–486PubMedCrossRef
17.
go back to reference Mok MY, Lo Y, Chan TM, Wong WS, Lau CS (2005) Tuberculosis in systemic lupus erythematosus in an endemic area and the role of isoniazid prophylaxis during corticosteroid therapy. J Rheumatol 32(4):609–615PubMed Mok MY, Lo Y, Chan TM, Wong WS, Lau CS (2005) Tuberculosis in systemic lupus erythematosus in an endemic area and the role of isoniazid prophylaxis during corticosteroid therapy. J Rheumatol 32(4):609–615PubMed
18.
go back to reference Mok CC, Birmingham DJ, Ho LY, Hebert LA, Rovin BH (2013) High-sensitivity C-reactive protein, disease activity, and cardiovascular risk factors in systemic lupus erythematosus. Arthritis Care Res 65(3):441–447CrossRef Mok CC, Birmingham DJ, Ho LY, Hebert LA, Rovin BH (2013) High-sensitivity C-reactive protein, disease activity, and cardiovascular risk factors in systemic lupus erythematosus. Arthritis Care Res 65(3):441–447CrossRef
19.
go back to reference Amezcua-Guerra LM, Springall R, Arrieta-Alvarado AA, Rodriguez V, Rivera-Martinez E, Castillo-Martinez D, Bojalil R (2011) C-reactive protein and complement components but not other acute-phase reactants discriminate between clinical subsets and organ damage in systemic lupus erythematosus. Clin Lab 57(7–8):607–613PubMed Amezcua-Guerra LM, Springall R, Arrieta-Alvarado AA, Rodriguez V, Rivera-Martinez E, Castillo-Martinez D, Bojalil R (2011) C-reactive protein and complement components but not other acute-phase reactants discriminate between clinical subsets and organ damage in systemic lupus erythematosus. Clin Lab 57(7–8):607–613PubMed
20.
go back to reference Pereira DSJ, Elkon KB, Hughes GR, Dyck RF, Pepys MB (1980) C-reactive protein levels in systemic lupus erythematosus: a classification criterion? Arthritis Rheum 23(6):770–771CrossRef Pereira DSJ, Elkon KB, Hughes GR, Dyck RF, Pepys MB (1980) C-reactive protein levels in systemic lupus erythematosus: a classification criterion? Arthritis Rheum 23(6):770–771CrossRef
21.
go back to reference Firooz N, Albert DA, Wallace DJ, Ishimori M, Berel D, Weisman MH (2011) High-sensitivity C-reactive protein and erythrocyte sedimentation rate in systemic lupus erythematosus. Lupus 20(6):588–597PubMedCrossRef Firooz N, Albert DA, Wallace DJ, Ishimori M, Berel D, Weisman MH (2011) High-sensitivity C-reactive protein and erythrocyte sedimentation rate in systemic lupus erythematosus. Lupus 20(6):588–597PubMedCrossRef
22.
go back to reference Shimojima Y, Matsuda M, Gono T, Ishii W, Ikeda S (2005) Relationship between clinical factors and neuropsychiatric manifestations in systemic lupus erythematosus. Clin Rheumatol 24(5):469–475PubMedCrossRef Shimojima Y, Matsuda M, Gono T, Ishii W, Ikeda S (2005) Relationship between clinical factors and neuropsychiatric manifestations in systemic lupus erythematosus. Clin Rheumatol 24(5):469–475PubMedCrossRef
23.
go back to reference Toledano P, Sarbu N, Espinosa G, Bargallo N, Cervera R (2013) Neuropsychiatric systemic lupus erythematosus: magnetic resonance imaging findings and correlation with clinical and immunological features. Autoimmun Rev 12:1166–1170PubMedCrossRef Toledano P, Sarbu N, Espinosa G, Bargallo N, Cervera R (2013) Neuropsychiatric systemic lupus erythematosus: magnetic resonance imaging findings and correlation with clinical and immunological features. Autoimmun Rev 12:1166–1170PubMedCrossRef
Metadata
Title
Discriminating infectious meningitis versus neuropsychiatric involvement in patients with systemic lupus erythematosus: a single-center experience
Authors
Jinyun Chen
Xuebing Feng
Hong Wang
Bingzhu Hua
Congzhu Ding
Bujun Liu
Lingyun Sun
Publication date
01-02-2015
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 2/2015
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-014-2726-8

Other articles of this Issue 2/2015

Clinical Rheumatology 2/2015 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.